Women in England with incurable breast cancer to get life-extending drug on NHS
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price. Thousands of women in England with incurable b…


Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.

No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Sun, Oct 11 | — | 0 |
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price. Thousands of women in England with incurable b…

Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news

AUSTIN, Texas, August 28, 2026--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a national partne…

I survived breast cancer. I wasn't prepared for what came next.
I was diagnosed with breast cancer 5 months ago. My first concern was how expensive treatment would be.
MIT computer-science professor Regina Barzilay lands on the MarketWatch 25 list of people who are reshaping how we live, work, save, spend and invest
Marissa Coreno thought the bump in her armpit was nothing, but colleagues encouraged her to check it out. Tests found Stage II breast cancer. Coreno underwent…

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE